ChemicalBook > CAS DataBase List > Tucotuzumab Celmoleukin
Tucotuzumab Celmoleukin
- Product Name
- Tucotuzumab Celmoleukin
- CAS No.
- 339986-90-2
- Chemical Name
- Tucotuzumab Celmoleukin
- Synonyms
- Tucotuzumab;Tucotuzumab Celmoleukin;Tucotuzumab (anti-EpCAM);Research Grade Tucotuzumab;Research Grade Tucotuzumab (DHD17404)
- CBNumber
- CB28080785
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Tucotuzumab Celmoleukin Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
N-Bromosuccinimide Price
Biorbyt Ltd
- Product number
- orb1980607
- Product name
- Tucotuzumab Antibody
- Purity
- 95.00%
- Packaging
- 1mg
- Price
- $260
- Updated
- 2026/05/06
Biorbyt Ltd
- Product number
- orb1980607
- Product name
- Tucotuzumab Antibody
- Purity
- 95.00%
- Packaging
- 5mg
- Price
- $610
- Updated
- 2026/05/06
Biorbyt Ltd
- Product number
- orb1980607
- Product name
- Tucotuzumab Antibody
- Purity
- 95.00%
- Packaging
- 10mg
- Price
- $940
- Updated
- 2026/05/06
Biorbyt Ltd
- Product number
- orb1980607
- Product name
- Tucotuzumab Antibody
- Purity
- 95.00%
- Packaging
- 25mg
- Price
- $1360
- Updated
- 2026/05/06
Biorbyt Ltd
- Product number
- orb1980607
- Product name
- Tucotuzumab Antibody
- Purity
- 95.00%
- Packaging
- 50mg
- Price
- $1820
- Updated
- 2026/05/06
More
Less
Tucotuzumab Celmoleukin Chemical Properties,Usage,Production
Uses
Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM). Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule[1].
in vivo
Tucotuzumab (75 μg; intratumoral injection; 5 daily of 15 μg (total dose of 75 μg), each in 50 μL PBS; on days 10 and 14) results in significantly greater tumor growth suppression and enhances survival[1].
| Animal Model: | Female Balb/c mice bearing CT26-KS colon adenocarcinoma[1] |
| Dosage: | 75 μg |
| Administration: | Intratumoral injection; 5 daily of 15 μg (total dose of 75 μg), each in 50 μL PBS; on days 10 and 14 |
| Result: | Resulted in significantly greater tumor growth suppression and enhanced survival. |
References
[1] Erik E Johnson, et al. Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma. Clin Cancer Res. 2009 Aug 1;15(15):4875-84. DOI:10.1158/1078-0432.CCR-09-0110
Tucotuzumab Celmoleukin Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Tucotuzumab Celmoleukin Suppliers
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 89686
- Advantage
- 60
- Tel
- 15971444841 17754423994
- Fax
- 18327183813
- candy@biochempartner.com
- Country
- China
- ProdList
- 3061
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ：422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9865
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 7081
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11972
- Advantage
- 58
- Tel
- 6206333 13167063860
- anhua.mao@aladdin-e.com
- Country
- China
- ProdList
- 49998
- Advantage
- 58
- Tel
- 15111215862 18229892877
- 3062105966@qq.com
- Country
- China
- ProdList
- 5432
- Advantage
- 58
- Tel
- 17316404525 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9774
- Advantage
- 58
- Tel
- 027-87008169 17762441161
- info@atagenix.com
- Country
- China
- ProdList
- 9998
- Advantage
- 58
339986-90-2, Tucotuzumab CelmoleukinRelated Search:
Lebrikizumab
Tanezumab
Codrituzumab
Robatumumab
Research Grade Tacatuzumab (DHC01501)
Vorsetuzumab
IMMunoglobulin G2
Denosumab
Pivekimab
Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer